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Abstract
Background: Identification of secreted proteins of low abundance is often limited by abundant and high
molecular weight (MW) proteins. We have optimised a procedure to overcome this limitation.
Results: Low MW proteins in the conditioned media of cultured cells were first captured using dual-size exclusion/
affinity hydrogel nanoparticles and their identities were then revealed by proteomics.
Conclusions: This technique enables the analysis of secreted proteins of cultured cells low MW and low
abundance.
Background
Secretory proteins are collectively referred as the secre-
tome, representing a major class of proteins located on or
within the extracellular matrix or exported into extracellu-
lar fluids [1]. Secretomes contain hundreds, possibly thou-
sands (depending on cell type and condition) of small to
medium sized (< 50 kDa) peptides and proteins that reflect
the physiological, metabolic and disease-associated biologi-
cal states [2]. Proteomic analysis of small and low abun-
dant secreted proteins is challenging requiring multiple
prior fractionation processes [3,4], with the inherent varia-
bility and the removal of proteins bound to their ‘non-spe-
cific’ binding partners [5,6]. A recent publication
demonstrates that low molecular weight (MW) proteins
can be captured from complex plasma proteins by dual
size exclusion/affinity nanoparticles (SEAN) [7]. The selec-
tive capturing involves the protein-binding of low MW
proteins to the cation core which is surrounded by a por-
ous acrylamide shell [8]. The nanoparticle sequesters low
MW peptides and proteins and excludes proteins > 20000
Da, thereby enriching low MW proteins.
During the secretory phase of the menstrual cycle in
women, the uterine stromal cells undergo a differentia-
tion process called decidualization which is critical for
pregnancy success. A poor decidual response is
associated with infertility and/or pregnancy related dis-
orders. Decidual cells are highly secretory and secreted
prolactin and insulin-like growth factors are used as
decidualization markers [9-11]. Further identification of
novel secreted proteins is critical in determining factors
that are important for decidualization and pregnancy
outcome. Primary stromal cells isolated from human
endometrium can be induced for decidualization in
vitro. To date, the identification of low abundant
secreted proteins has been restricted.
In this study, we successfully combined SEAN and
proteomics to reveal secreted proteins of primary
human decidual cells. This is the first publication
describing a detailed protocol to first enrich secreted
low MW proteins from cultured cells using SEAN, then
to reveal their identities by proteomics.
Results and Discussion
Precipitation and SEAN of cultured media confirms
success by SELDI-TOF mass spectroscopy (MS)
Decidualized and control cultured media were subjected
to SEAN to capture low MW proteins from the complex
protein mixture (Figure 1A). This procedure was pre-
viously performed in plasma [7] and SELDI-ToF MS con-
firmed the success of SEAN in cultured media by
comparing the MW of SEAN-bound (small MW, proteins
bound) and unbound (large MW such as BSA) proteins.
SELDI-ToF profile of SEAN-bound fractions (< 25 000 m/
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molecular MW proteins (> 25 000 m/z) including BSA
were completely removed in the SEAN bound fraction in
both control and decidualized cell media (Figure 1B). We
next compared the SELDI-ToF profile of SEAN-bound
fractions (< 25 000 m/z) of control and decidualized
media (Figure 2A). A number of protein peaks were pre-
sent in the decidualized fraction but were not present in
control fraction (asterisks, Figure 2A). Furthermore, Prin-
ciple Components Analysis (PCA) demonstrated a clear
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Figure 1 Schematic diagram showing SEAN captures low MW proteins but leaves high MW proteins in culture media.( A) The process
of capturing low MW proteins from cultured media using SEAN. (B) Representative SELDI-ToF profiles shows the removal of albumin in SEAN-
captured (control and decidualized) media samples. Albumin was absent in SEAN-bound (a and b) but present in SEAN-unbound proteins (c and
d). Proteins over the range of 0-150 000 m/z are shown.
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Page 2 of 6difference in the secretomes between decidual and control
cells (Figure 2B). These confirmed that SEAN procedure
removed large MW proteins and enriched small MW pro-
teins for further MS analysis.
Identification of SEAN-bound proteins of decidual and
control media
We then analysed the SEAN-bound proteins of decidual
and control media by proteomics. A total of 219 pro-
teins were identified in the cultured media, 184 of
which were from decidual media and 35 from control
media (Additional file 1, Additional file 2 and Additional
file 3). Of the 218 proteins from decidual cells, only 52
identified proteins were exclusively expressed in humans
(Figure 3 and Additional file 3). Twenty-nine of these
proteins (55.8%) contain a unique peptide fragment, the
spectra of which were manually validated (Figure 3A).
This is not surprising considering SEAN enriches pro-
teins of small MW proteins. For the 52 identified pro-
teins, Multiloc was applied to predict the subcellular
localization (Figure 3B) [12]. Multiloc is based on the
recognition of N-terminal targeting sequences, the over-
all amino acid composition, sequence motifs extracted
from the database of nuclear localization signals [13]
and the PROSITE database [14]. 53.8% were predicted
to be secreted or potentially secreted, whilst 30.8% were
localized to the cytoplasm, 7.7% to the nucleus or mem-
brane (Figure 3B).





















Figure 2 Comparison of SEAN-bound proteins from control and decidualized cell media.( A) Representative SELDI-ToF profiles shows a
clear difference between control and decidualized media over the range of 0-25 000 m/z. (B) Principle components analysis (PCA) of all
significant protein peaks, revealing a dramatic separation between the two groups over 4 separate experiments.
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The PANTHER (Protein ANalysis THrough Evolutionary
Relationships) classification system was used to classify the
52 decidual proteins according to their molecular func-
tions (Figure 3C) [15,16]. A large percent (86.9%) were
involved in binding, catalytic, enzyme regulatory and
structural molecular activity. These are important for cell
remodeling which is an essential component of deciduali-
zation. For example; the extracellular matrix protein, lami-
nin subunit- beta 1 bind to integrins at the time of
implantation thereby allowing blastocyst-endometrium
interaction [17-19]. The identification of metalloproteinase
inhibitor (MMP) 1 and HTRA1 in media of decidual cells
highlights the power of SEAN. MMP inhibitors are known
to be produced by decidual tissues throughout gestation
[20-22]. Additional in vitro studies suggest that MMPs
and their inhibitors must be finely regulated for implanta-
tion and pregnancy success [22,23].
Conclusions
In summary, this study demonstrates that SEAN is a
powerful fractionation strategy to remove a majority of
serum containing proteins including albumin in the cell
media to unmask low abundant secreted proteins.
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Figure 3 Mass spectrometry analysis of secreted proteins from decidualized cells. Stratification of proteins of interest was based on the
number of peptides contributing to their identification (A), subcellular localization (B) and molecular function (C). (A) Representative SELDI-ToF
profiles shows a clear difference between control and decidualized media over the range of 0-25 000 m/z. (B) Principle components analysis
(PCA) of all significant protein peaks, revealing a dramatic separation between the two groups over 4 separate experiments.
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the identification of low abundant and low MW secreted
proteins. The described protocol is based on decidual cell
media and is equally applicable to other cell experiments.
Methods
Isolation and culture of human endometrial tissue
Ethical approval was obtained for all tissue collections
from the Human Ethics Committee at Monash Medical
Centre, Melbourne, Australia. Written and informed
consent was obtained from all patients. Human uterine
biopsies (days 8-24 of the menstrual cycle) was obtained
from fertile women undergoing curettage. Samples were
collected in Dulbecco’s modified Eagle’sm e d i u m / F 1 2
(DMEM/F12; Sigma, St. Louis, MO) and processed
within 24 hr. Human endometrial stromal cells (HESC)
were isolated by enzymatic digestion and filtration as
previously described [24]. Cells were decidualized with
8-bromoadenosine cAMP (500 μM), estradiol (E2;1 0
-8
M) and medroxyprogesterone acetate (MPA; 10
-7 M)
(all from Sigma) for 96 hours in DMEM/F12 containing
0.1% BSA. HESC treated with vehicle served as controls.
At the end of the 96 hours, culture media was collected,
aliquoted and stored at -80°C until analysis. The success
of decidualization was confirmed by a significant
increase in prolactin secretion (data not shown). Four
biological replicates were conducted and pooled (4 con-
trols and 4 decidual) for SEAN and proteomic analysis.
Precipitation and SEAN of cultured media
Media from successfully decidualized and control stro-
mal cells were thawed rapidly to room temperature and
SEAN experiment was performed as described with
modifications [7]. Precipitation and SEAN procedures
were undertaken at room temperature unless suggested
otherwise. Samples were precipitated with acetone in
the dark overnight, and centrifuged (10 000 g/20 mins;
Beckman JS7.5 rotor, NSW, Australia). The protein pel-
let was dried (maximum of 10 mins) and resuspended
i n2m lo fb i n d i n gb u f f e r( M E S1 0m M ,N a C l1 0m M ,
pH 6). Precipitated proteins were solubilized in 2 ml
binding buffer, mixed with the washed SEAN pellets,
briefly vortexed and incubated for 20 mins. Following
centrifugation (14 000 × g/10 mins), the pellet was vig-
orously resuspended and washed three times in 2 ml
binding buffer containing 0.1% (w/v) n-Octyl b-D-gluco-
pyranoside (OGP) (Sigma), and then three times in 2 ml
of ice-cold distilled, deionized water. Low MW proteins
remained bound to SEAN pellet, whilst high MW pro-
teins remained unbound. The SEAN pellets were incu-
bated with 200 μl elution buffer [80% acetonitrile (v/v;
Merck, Darmstadt, Germany), 0.1%trifluoroacetic acid
(TFA) v/v (Sigma)] for 5 mins and centrifuged at 21 000
g/10 mins (Eppendorf 5415 rotor, Hamburg, Germany)
to recover the bound proteins. This procedure was per-
formed twice to maximize recovery.
SELDI-ToF MS
Proteins fractions from SEAN-bound and unbound pro-
teins were concentrated at 60°C in a centrifugal concen-
trator (Eppendorf) to ~10 μl volume, and applied to Gold
ProteinChip Array (BioRad, Hercules, CA) and analyzed
using a ProteinChip Reader Series 4000 Personal Edition
(BioRad) in positive ion mode. Spectra were acquired in
the range 1 500-25 000 Da or 25 000-140 000 Da using
an average of 2150 laser shots, 1800 nJ laser intensity and
800 MHz sampling rate. External calibration of the Pro-
teinChip Reader was performed using the all-in protein/
peptide standard (BioRad). The mass spectra were ana-
lyzed using Ciphergen Express Client version 3.0.6 soft-
ware. Baseline subtraction and normalization on total ion
current were performed for all spectra within a single
experiment prior to comparative analyses.
Identification of SEAN-bound proteins by MS
Proteins extracted from the SEAN were diluted with 40 μl
of 100 mM ammonium bicarbonate (Sigma) and reduced
with 5 mM DTT (Sigma) at 56°C for 30 mins. Samples
were incubated with 55 μl of 50 mM ammonium bicarbo-
nate and 25 mM of iodoacetamide (Sigma) for 30 mins at
room temperature to alkylate thiol groups. Trypsin (pro-
tein: trypsin, 50:1, Promega, Madison, WI) was added and
samples were digested overnight at 37°C in a humidified
chamber. The peptide mixture was fractionated by nano-
flow reversed-phase (RP) liquid chromatography using a
1200 series Capillary HPLC (Agilent Technologies, Santa
Clara, CA) online equipped with a nanoAcquity C18
150150 × 1.0 mm i.d. column (Waters, Milford, MA), at
0.5 μl/min flow rate at 45°C in a linear gradient from
100% solvent A (0.1% v/v formic acid) to solvent B (0.1%
v/v aqueous formic acid, 60% acetonitrile). Mass spectra
were acquired using LTQ-Orbitrap mass spectrometer
(Thermo Fisher Scientific, Waltham, MA) for automated
MS/MS. Data dependent MS was analysed by acquiring
one FTMS scan followed by MS2 on the top five most
intense ions. Dynamic exclusion was enabled at repeat
count 1, exclusion list size 500, exclusion duration 180 s,
and exclusion mass width +/- 1.5 m/z. Collision induced
dissociation was performed by setting the ion isolation
width at 2 m/z, normalized collision energy at 35%, activa-
tion Q at 0.25 and an activation time at 30 ms.
Acquired spectra were searched against combinations
of UniProtKB_SwissProt (release version 13.3), Uni-
prot_SwissProt (release version 13.3), UniProtKB_-
TrEMBL (release version 40.3) and ipi.HUMAN (release
version 3.59) using Phenyx (Geneva Bioinformatics,
Switzerland, http://phenyx.vital-it.ch/docs/pwi/PWITOC.
html). Reverse databases for the above were searched to
Paule et al. Proteome Science 2011, 9:50
http://www.proteomesci.com/content/9/1/50
Page 5 of 6calculate false discovery rates. Search restrictions were
carbamidomethylation (CAM-fixed modification), oxida-
tion of methionine (variable modification), a parent ion
mass tolerance of 20 ppm and 3 missed tryptic cleavage
site. Precursor ion mass tolerance was set at 1.5 Da plus
an allowance for one
13C. Each sample was analyzed by
three separate injections and subsequent mass spectral
analysis.
Additional material
Additional file 1: Table S1. Secretome of proteins from control media
captured and identified by mass spectrometry.
Additional file 2: Table S2. Secretome proteins from decidualized
media by SEAN and identified by mass spectroscopy that did not meet
inclusion criteria.
Additional file 3: Table S3. Secretome proteins captured by SEAN and
identified by mass spectrometry that met the inclusion criteria. The
numbers listed in rows indicate the number of distinct peptides
identified by mass spectrometry from the media of decidualized cells.
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